TNSN06223A1 - Direct compression formulation and process - Google Patents

Direct compression formulation and process

Info

Publication number
TNSN06223A1
TNSN06223A1 TNP2006000223A TNSN06223A TNSN06223A1 TN SN06223 A1 TNSN06223 A1 TN SN06223A1 TN P2006000223 A TNP2006000223 A TN P2006000223A TN SN06223 A TNSN06223 A TN SN06223A TN SN06223 A1 TNSN06223 A1 TN SN06223A1
Authority
TN
Tunisia
Prior art keywords
dpp
direct compression
acceptable
formulation
tablets
Prior art date
Application number
TNP2006000223A
Other languages
French (fr)
Inventor
Arun P Patel
James Kowalski
Lakshman Jayanth Parthiban
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39962907&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN06223(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2005/000400 external-priority patent/WO2005067976A2/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TNSN06223A1 publication Critical patent/TNSN06223A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Dipeptidylpeptidase IV inhibitor (herein referred to as DPP-IV) that may be 98.5-100% pure is a high-dose drug capable of being directly compressed with specific excipients into sold form dosage forms, such as tablets and capsules having desired, hardness, disintegrating ability and acceptable dissolution characteristics. DPP-IV is not inherently compressible and thus presents formulation problems. Excipients used in the formulation enhance the flow and compaction properties of the drug and tableting mix. Optimal flow contributes to uniform die fill and weight control. The binder used ensures sufficient cohesive properties that allow DPP-IV to be compressed using the direct compression method. The tablets produced provide an acceptable in vitro dissolution profile.
TNP2006000223A 2004-01-20 2006-07-19 Direct compression formulation and process TNSN06223A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53770604P 2004-01-20 2004-01-20
PCT/EP2005/000400 WO2005067976A2 (en) 2004-01-20 2005-01-17 Direct compression formulation and process

Publications (1)

Publication Number Publication Date
TNSN06223A1 true TNSN06223A1 (en) 2007-12-03

Family

ID=39962907

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000223A TNSN06223A1 (en) 2004-01-20 2006-07-19 Direct compression formulation and process

Country Status (4)

Country Link
CN (2) CN101618216B (en)
AR (1) AR099137A2 (en)
TN (1) TNSN06223A1 (en)
ZA (1) ZA200605513B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104856970B (en) * 2015-06-23 2017-08-25 张磊 A kind of vildagliptin tablet for treating type II diabetes
CN105233300B (en) * 2015-11-05 2019-10-25 北京泰德制药股份有限公司 A kind of stable vildagliptin composition and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131402A1 (en) * 1981-08-07 1983-02-24 Kilian & Co GmbH, 5000 Köln METHOD AND TABLET PRESS FOR THE SUCCESSFUL PRODUCTION OF A VARIETY OF TABLETS OF THE SAME WEIGHT
DE19823831A1 (en) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim New pharmaceutical use of isoleucyl thiazolidide and its salts
FR2822826B1 (en) * 2001-03-28 2003-05-09 Servier Lab NOVEL ALPHA-AMINO ACID SULPHONYL DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2824825B1 (en) * 2001-05-15 2005-05-06 Servier Lab NOVEL ALPHA-AMINOACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2005519052A (en) * 2002-01-11 2005-06-30 アスファルマ リミテッド Pravastatin pharmaceutical preparation and method of use thereof
JP2003327532A (en) * 2002-05-10 2003-11-19 Takeda Chem Ind Ltd Peptidase inhibitor

Also Published As

Publication number Publication date
CN101262851A (en) 2008-09-10
CN101618216A (en) 2010-01-06
CN101618216B (en) 2012-01-04
AR099137A2 (en) 2016-06-29
ZA200605513B (en) 2007-11-28

Similar Documents

Publication Publication Date Title
PH12019501331A1 (en) Direct compression formulation and process
TW200716175A (en) Direct compression formulation and process
TNSN07274A1 (en) Direct compression formulation and process
WO2008057266A3 (en) Dry granulation binders, products, and use thereof
TW200633730A (en) Oral disintegrating dosage forms
MX2008012731A (en) Fast release paracetamol tablets.
HK1067544A1 (en) Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
WO2009043844A3 (en) Orodispersible tablets
MXPA04012464A (en) Orally disintegrating tablets and process for obtaining them.
MXPA03001407A (en) Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor.
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
WO2003059329A3 (en) Polytartrate composition
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
ZA200506992B (en) Fibrate tablet and method for the production thereof
TNSN06223A1 (en) Direct compression formulation and process
WO2002092056A8 (en) Compaction process for manufacture of sodium phenytoin dosage form
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
SI1596841T1 (en) Therapeutic system comprising amoxicillin and clavulanic acid
US6692765B1 (en) Exactly divisible tablet
EP1416918A4 (en) Synergistic filler composition
WO2004105691A3 (en) Pharmaceutical compositions for oral administration comprising lithium carbonate
YU54503A (en) Pharmaceutical composition containing citalopram
PL1499278T3 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
CA2469327A1 (en) Propafenone hydrochloride capsules containing microtablets
WO2005009395A3 (en) Cellulosic fiber containing composition